The I-SPY clinical trial platform was designed to accelerate clinical development of neoadjuvant treatments for early-stage breast cancer. Although it is not without limitations, it provides a model for future response-adapted clinical trials.
- Jose Pérez-García
- Gabriele Antonarelli
- Javier Cortés
